logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Taris Biomedical LLC


USPTO Granted Patents = 59



Forward Citations = 262

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Heejin Lee (43 out of 53 patents)

silverMedal Karen Danielle Daniel (21 out of 25 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (16 out of 21 patents)

5.  Michael John Cima (10 out of 105 patents)

6.  Matthew Sansone (8 out of 9 patents)

7.  Burleigh M Hutchins, Iii (6 out of 12 patents)

8.  Hong Linh Ho Duc (6 out of 9 patents)

9.  Grace Kim (4 out of 7 patents)

10.  Paul C DiCesare (3 out of 77 patents)

11.  Andrew Barnes (3 out of 7 patents)

12.  Eric Britschock (3 out of 3 patents)

13.  David Sutton (3 out of 3 patents)

14.  Jeffrey P Radziunas (3 out of 60 patents)

15.  Jim Boyko (3 out of 3 patents)


Core Competencies:
Drug Delivery Devices
Intravesical Drug Delivery
Implantable Drug Delivery
Bladder Cancer Treatment
Overactive Bladder Therapy
Multi-lumen Devices
Elastic Polymer-drug Matrix
Genitourinary Drug Delivery
Solid Drug Tablets
Tumor Metastasis Treatment
Controlled Drug Release
Urological Devices

59 patents:

1. 12447241 - Multi-unit drug delivery devices and methods (2025-10-21),
2. 12409304 - Drug delivery devices with drug-permeable component and methods (2025-09-09),
3. 12403086 - Solid drug tablets for implantable drug delivery devices (2025-09-02),
4. 12263244 - Intravesical device for controlled drug delivery (2025-04-01),
5. 12239807 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2025-03-04),
6. 12214148 - Multi-lumen drug delivery devices and methods (2025-02-04),
7. 12133913 - Methods of treating overactive bladder using trospium (2024-11-05),
8. 12090292 - Drug delivery devices and methods for drug delivery (2024-09-17),
9. 12059428 - Methods of treating tumor metastasis (2024-08-13),
10. 12029749 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2024-07-09),
11. 11992583 - Drug delivery devices and methods (2024-05-28),
12. 11904123 - Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems (2024-02-20),
13. 11890439 - Drug delivery device with intravesical tolerability (2024-02-06),
14. 11850244 - Drug delivery systems and methods for treatment of bladder dysfunction or disorder using trospium (2023-12-26),
15. 11844856 - Solid drug tablets for implantable drug delivery devices (2023-12-19),
TARIS Biomedical LLC is a leading biopharmaceutical company focused on developing innovative therapies to treat serious diseases. They specialize in the design and delivery of targeted therapies for urological and gastrointestinal disorders using their proprietary drug delivery technology. With a mission to improve the lives of patients, TARIS Biomedical combines expertise in drug delivery, biomaterials, and clinical development to advance therapeutic solutions. Visit their website for more information and updates on their groundbreaking research and product development.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
59 Patents

#17 in Lexington, MA

#337 in Massachusetts

#5,907 in US

#11,951 in the World

...
Lexington, MA, United States of America

Taris Biomedical LLC

Forward Citations = 262

23 inventors:

goldMedal Heejin Lee (43 out of 53 patents)

silverMedal Karen Danielle Daniel (21 out of 25 patents)

bronzeMedal Cheryl Larrivee-Elkins (17 out of 23 patents)

4.  Dennis Giesing (16 out of 21 patents)

5.  Michael John Cima (10 out of 105 patents)

Please report any incorrect information to support@idiyas.com
Loading…